Securities and Finance

Financial Risk Management

Financial Risk Management

As risk management has become a critical part of strategic planning, businesses are recognizing the need to evaluating the “risk landscape” of their firm in the aggregate, rather than just measuring and managing individual risks one at a time. With extensive professional experience in risk analysis and risk management techniques, NERA's Financial Risk Management experts are well versed in modeling, analyzing, and communicating the effects of combined risks to financial and non-financial institutions. Our experts assist clients in measuring individual risk exposures and aggregating these risks across risk factors and business units, taking into account correlations and diversification effects, to measure their combined effect on performance measures such as earnings-at-risk or cash-flow-at-risk. Clients benefit by having an improved quantification of the risks they face, a better assessment of the impact of their risk transfer activities -- hedging and insurance -- on their overall risk, more precise contingency planning, and more accurate budgeting and financial planning.

NERA experts are recognized as thought leaders in the field of risk management, and have a distinct ability to evaluate the trends that are likely to represent the best practices of tomorrow. NERA's experts have assisted various industry bodies, such as the Group of Thirty, the International Swaps and Derivatives Association, and the Treasury Management Association, in developing risk management principles and evaluating best practices.

Name Title Location Phone Email
Lucy P. Allen Senior Managing Director New York City +1 212 345 5913 lucy.allen@nera.com
Dr. Denise Neumann Martin Senior Managing Director Miami +1 305 808 7880 denise.martin@nera.com
Dr. Faten Sabry Senior Managing Director
Chair of NERA's Global Securities and Finance Practice
Bankruptcy Practice Chair
New York City
London
+1 212 345 3285
+44 20 7659 8618
faten.sabry@nera.com
Adam Warren Senior Managing Director Chicago +1 (312) 573-2821 adam.warren@nera.com
Dr. Ling Ling Ang Managing Director Washington, DC
Chicago
+1 202 466 9259
+312 573 2827
lingling.ang@nera.com
Dr. Jordan Milev Managing Director New York City +1 212 345 5516 jordan.milev@nera.com
Dr. Airat Chanyshev Director New York City +1 212 345 7336 airat.chanyshev@nera.com
Drew Claxton Director New York City +1 212 345 3442 drew.claxton@nera.com
Dr. Sharon Brown-Hruska Affiliated Consultant Washington, DC +1 202 466 3510 sharon.hruska.affiliate@nera.com
Dr. Andrew Carron Affiliated Consultant New York City
London
+1 212 345 5407
+44 20 7659 8500
andrew.carron.affiliate@nera.com
Dr. James Overdahl Affiliated Industry Expert Washington, DC +1 202 547 3035 joverdahl@deltastrat.com
Title Type Author
Recent Trends in Securities Class Action Litigation: H1 2023 Update Report Edward Flores and Svetlana Starykh
Trends in Canadian Securities Class Actions: 2021 Update White Paper Bradley A. Heys, Robert Patton, Jielei Mao
Class Action Lawsuits: Opportunities to Apply Econometrics and Statistics Published Article Dr. Ling Ling Ang, Dr. Jordan Milev, and Dr. John Scalf
Fintech Developments and Antitrust Considerations in Payments Published Article Dr. Ling Ling Ang and Dr. Will Taylor
The Role of Punitive Damages in Asbestos Litigation Published Article Faten Sabry and Sungi Lee, et al.
Recent Trends in Securities Class Action Litigation Janeen McIntosh and Svetlana Starykh
Trends in Canadian Securities Class Actions: 2020 Update Report Bradley A. Heys, Robert Patton, and Jielei Mao
Recent Trends in Securities Class Action Litigation: 2020 Full-Year Review Report Janeen McIntosh and Svetlana Starykh
Recent Trends in Securities Class Action Litigation: H1 2020 Update Report Janeen McIntosh and Svetlana Starykh
How COVID-19 Impact Analysis May Shape MAE Disputes Published Article Dr. David Tabak and Edward Flores